Prospective Therapeutic Applications of Platelet Extracellular Vesicles

被引:93
作者
Johnson, Jancy [1 ,2 ]
Wu, Yu-Wen [3 ]
Blyth, Chantelle [1 ]
Lichtfuss, Gregor [1 ,2 ]
Goubran, Hadi [4 ,5 ]
Burnouf, Thierry [3 ,6 ,7 ]
机构
[1] Exopharm Ltd, Level 17,31 Queen St, Melbourne, Vic 3000, Australia
[2] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia
[3] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan
[4] Univ Saskatchewan, Saskatoon Canc Ctr, Saskatoon, SK, Canada
[5] Univ Saskatchewan, Coll Med, Saskatoon, SK, Canada
[6] Taipei Med Univ, Coll Biomed Engn, Int PhD Program Biomed Engn, Taipei, Taiwan
[7] Taipei Med Univ, Coll Med, Int PhD Program Cell Therapy & Regenerat Med, Taipei, Taiwan
关键词
MICROPARTICLES INDUCE ANGIOGENESIS; DRUG-DELIVERY; EXOSOMES; ACTIVATION; MEMBRANE; CANCER; NANOFILTRATION; INFLAMMATION; AGGREGATION; TRANSFUSION;
D O I
10.1016/j.tibtech.2020.10.004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
There is much interest in the use of extracellular vesicles (EVs) as a subcellular therapy for regenerative medicine and drug delivery. Blood-borne platelets represent a source of therapeutic EVs that is so far largely unexplored. Advantages of platelets as a cellular source of EVs include their established clinical value, regulated collection procedures, availability in a concentrated form, propensity to generate EVs, and unique composition and tissue-targeting capacity. This review analyzes the unique potential of platelet-derived (p-) EVs as therapeutic modalities and presents their inherent translational advantages for hemostasis, for regenerative medicine, and as drug-delivery vehicles. Researchers in academic fields and the cell therapy and biotechnology industries have a great interest in the translational potential of EVs (see Glossary), which, as described by the International Society of Extracellular Vesicles (ISEV) is 'a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, and apoptotic bodies', among others [1]. These heterogeneous cell-derived vesicles are 'delimited by a
引用
收藏
页码:598 / 612
页数:15
相关论文
共 92 条
[1]   Isolation and characterization of platelet-derived extracellular vesicles [J].
Aatonen, Maria T. ;
Ohman, Tiina ;
Nyman, Tuula A. ;
Laitinen, Saara ;
Gronholm, Mikaela ;
Siljander, Pia R. -M. .
JOURNAL OF EXTRACELLULAR VESICLES, 2014, 3 (01)
[2]   Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug updates delivery applications and enhanced translational potential [J].
Agrahari, Vibhuti ;
Burnouf, Pierre-Alain ;
Burnouf, Thierry ;
Agrahari, Vivek .
ADVANCED DRUG DELIVERY REVIEWS, 2019, 148 :146-180
[3]   Extracellular Microvesicles as New Industrial Therapeutic Frontiers [J].
Agrahari, Vivek ;
Agrahari, Vibhuti ;
Burnouf, Pierre-Alain ;
Chew, Chee Ho ;
Burnouf, Thierry .
TRENDS IN BIOTECHNOLOGY, 2019, 37 (07) :707-729
[4]   Comparison of the release of microRNAs and extracellular vesicles from platelets in response to different agonists [J].
Ambrose, Ashley R. ;
Alsahli, Mohammed A. ;
Kurmani, Sameer A. ;
Goodall, Alison H. .
PLATELETS, 2018, 29 (05) :446-454
[5]   Storage pool diseases illuminate platelet dense granule biogenesis [J].
Ambrosio, Andrea L. ;
Di Pietro, Santiago M. .
PLATELETS, 2017, 28 (02) :138-146
[6]   Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery [J].
Antimisiaris, Sophia G. ;
Mourtas, Spyridon ;
Marazioti, Antonia .
PHARMACEUTICS, 2018, 10 (04)
[7]   Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells [J].
Barro, Lassina ;
Nebie, Ouada ;
Chen, Ming-Sheng ;
Wu, Yu-Wen ;
Koh, Mickey B. C. ;
Knutson, Folke ;
Watanabe, Naoto ;
Takahara, Masayasu ;
Burnouf, Thierry .
CYTOTHERAPY, 2020, 22 (08) :458-472
[8]   Megakaryocytes package contents into separate α-granules that are differentially distributed in platelets [J].
Battinelli, Elisabeth M. ;
Thon, Jonathan N. ;
Okazaki, Ross ;
Peters, Christian G. ;
Vijey, Prakrith ;
Wilkie, Adrian R. ;
Noetzli, Leila J. ;
Flaumenhaft, Robert ;
Italiano, Joseph E., Jr. .
BLOOD ADVANCES, 2019, 3 (20) :3092-3098
[9]   Staphylococcal SSL5-induced platelet microparticles provoke proinflammatory responses via the CD40/TRAF6/NFκB signalling pathway in monocytes [J].
Bei, Jun-Jie ;
Liu, Chuan ;
Peng, Song ;
Liu, Cheng-Hai ;
Zhao, Wei-Bo ;
Qu, Xiao-Long ;
Chen, Qiang ;
Zhou, Zhou ;
Yu, Zheng-Ping ;
Peter, Karlheinz ;
Hu, Hou-Yuan .
THROMBOSIS AND HAEMOSTASIS, 2016, 115 (03) :632-645
[10]   Extracellular vesicles and coagulation in blood from healthy humans revisited [J].
Berckmans, Rene J. ;
Lacroix, Romaric ;
Hau, Chi M. ;
Sturk, Auguste ;
Nieuwland, Rienk .
JOURNAL OF EXTRACELLULAR VESICLES, 2019, 8 (01)